Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
46.98 USD | +2.12% |
|
+7.45% | +64.54% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+64.54% | 7.59B | |
+26.06% | 46.56B | |
+45.38% | 41.67B | |
-0.07% | 41.16B | |
+32.86% | 32.4B | |
+20.62% | 28.18B | |
-6.35% | 28.1B | |
+48.97% | 14.52B | |
+47.66% | 13.74B | |
+3.34% | 12.17B |
- Stock Market
- Equities
- RVMD Stock
- News Revolution Medicines, Inc.
- Oppenheimer Adjusts Revolution Medicines Price Target to $55 From $45, Maintains Outperform Rating